UVision is heading to Nasdaq at $3.5B. It never had a sales problem.

An Israeli drone company. A $982 million U.S. Army contract. JPMorgan leading the IPO.

But here's what the headline doesn't tell you:

UVision didn't plateau. They didn't stall. They didn't wonder why the pipeline dried up.

They knew exactly what they were selling, to whom, and why it mattered and they scaled accordingly.

Most B2B companies I work with are the opposite.

Good product. Working team. And revenue that hasn't moved in 6 months.

That's not a sales problem. That's a strategy problem dressed up as a sales problem.

It's almost always one of these: Targeting the right industry but the wrong buyer inside it Positioning that sounds identical to every competitor A sales motion built for early adopters that breaks on mainstream buyers No one actually owns the revenue strategy. Not really.

UVision had wars validate their product for them.

You don't get that luxury.

You need someone who can walk in, diagnose fast, and build the go-to-market infrastructure that moves the number.

That's what I do.

I'm Tal Paperin Fractional CRO, 20+ years in B2B across multiple industries and geographies, clients from early-stage startups to PepsiCo and Del Monte.

No retainer bloat. No 6-month onboarding. No fluff.

If revenue has been stuck and you can't figure out why that's exactly the problem I solve.

DM me. Let's find it.